IL6 and COVID-19: Biomarkers indicating rapid deterioration in COVID-19 patients are mostly represented by troponin I (TnI), CRP, erythrocyte sedimentation rate (ESR), D-dimer, progressive deterioration of lymphocyte counts and elevated inflammatory markers (IL-6, TNF-α).